EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Addressing the Challenge of Successful One-Stage Lumpectomy for DCIS

Joshua A Feinberg iD, Pabel Miah iD, Charles DiMaggio, Nakisa Pourkey, Jennifer Chun Kim, Jenny Goodgal, Amber Guth, Deborah Axelrod, Freya Schnabel

The American Surgeon™ · 2025

DOI: 10.1177/00031348251329496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, 2025. Verfasst von Joshua A Feinberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, New York University Grossman School of Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Mastectomy, Segmental, Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Reoperation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast conserving surgery represents the preferred surgical treatment option for patients with early-stage breast cancer. Reexcision rates are generally higher for patients undergoing lumpectomies for ductal carcinoma in situ (DCIS) compared to invasive breast cancer, as the microscopic extent of disease is difficult to assess during excision. This study investigated the clinicopathological characteristics of patients undergoing BCS for pure DCIS and reexcision rates over time, including the effect of the MarginProbe™ device.

Methods

We queried our prospectively maintained Institutional Breast Cancer Database for patients diagnosed with DCIS and treated with BCS as their primary procedure from 2010-2021. The primary endpoint was the rate of reexcision. Variables of interest included age at diagnosis, race/ethnicity, mode of diagnostic imaging, mammographic breast density, method of core biopsy, nuclear grade, size of DCIS, multifocality, DCIS subtype, and MarginProbe™ use.

Results

Papillary DCIS ( P < 0.004) and larger size ( P < 0.001) was associated with an increased reexcision rate. There were also differences in the method of core biopsy ( P < 0.001), with stereotactic core biopsy predominating among patients who did not require reexcision (71.3% vs 49.5%). In an unadjusted estimate for the odds ratio for association, patients who had MarginProbe™ used were 81% less likely to require reexcision (OR = 0.19, 95% CI = 0.12, 0.31, P < 0.0001).

Conclusion

Younger age, papillary DCIS, larger DCIS size, and non-stereotactic core biopsy method were found to be associated with higher reexcision rates. Additionally, patients whose primary procedures included intraoperative margin assessment with the MarginProbe™ were significantly less likely to require reexcision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mastectomy, SegmentalCarcinoma, Intraductal, NoninfiltratingBreast NeoplasmsReoperationHumansFemaleMiddle AgedAgedAdultRetrospective StudiesMargins of Excision

Stichwörter der Autor:innen

DCISductal carcinoma in situmargins

Autor:innen und Institutionen

  • Department of Surgery, New York University Grossman School of Medicine, New York, NY, USA.

ORCID-Profile: Joshua A Feinberg, Pabel Miah

Zitieren

APA

Feinberg, J. A., Miah, P., DiMaggio, C., Pourkey, N., Chun Kim, J., Goodgal, J., Guth, A., Axelrod, D., & Schnabel, F. (2025). Addressing the Challenge of Successful One-Stage Lumpectomy for DCIS. The American Surgeon™. https://doi.org/10.1177/00031348251329496

Vancouver

Feinberg JA, Miah P, DiMaggio C, Pourkey N, Chun Kim J, Goodgal J, et al. Addressing the Challenge of Successful One-Stage Lumpectomy for DCIS. The American Surgeon™. 2025. doi:10.1177/00031348251329496

BibTeX
@article{Feinberg2025,
  author = {Feinberg, Joshua A and Miah, Pabel and DiMaggio, Charles and Pourkey, Nakisa and Chun Kim, Jennifer and Goodgal, Jenny and Guth, Amber and Axelrod, Deborah and Schnabel, Freya},
  title = {Addressing the Challenge of Successful One-Stage Lumpectomy for DCIS},
  journal = {The American Surgeon™},
  year = {2025},
  doi = {10.1177/00031348251329496}
}
Kostenlos starten →